CNS presentation of Lyme disease
CNS presentation of Lyme disease CNS presentation of Lyme disease
Antibiotic choice for neuroborreliosis• Ceftriaxone was effective in cases ofneuroborreliosis where penicillin had failed, and canalso be used in children with neurological involvement– Dattwyler RJ, et al. Ceftriaxone as effective therapy in refractory Lymedisease J Infect Dis 1987; 155: 1322–1324• Among patients with Lyme encephalopathy,characterized by loss of memory, ceftriaxone is ableto improve the clinical signs in some, but not all, cases– Logigian EL, : Successful treatment of Lyme encephalopathy withintravenous ceftriaxone. J Infect Dis 1999; 180: 377–383.
Doxyxyclin and neuroborreliosis• Several studies show equivalent efficacy (200mg/day, 3 weeks) compared to ceftriaxone and highdosageintravenous penicillin• Karlsson M, et al.: Comparison of intravenous penicillin G and oral doxycycline for treatment of Lymeneuroborreliosis. Neurology 1994; 44: 1203–1207.• Dattwyler RJ, et al:Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lymeborreliosis. N Engl J Med 1997; 337: 289–294.• Dotevall L, et al. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. ClinInfect Dis 1999; 28: 569–574.• In other studies, neurological complications occurredafter doxycycline treatment,– poorly diffusion into the CSF ?– When dosage increased to 400 mg/day : equivalence to ceftriaxone• Borg R, et al.: Intravenous ceftriaxone compared with oral doxycycline for the treatment ofLyme neuroborreliosis. Scand J Infect Dis 2005; 37: 449–454.• Oral doxycycline as efficient as intravenousceftriaxone– inclusion criteria including patients with Bb antibodies in serum,without any other biological criteria• Ljostad Lancet Neurology, 2008 ; 7 : 6988-690.
- Page 5 and 6: The answer• If your referenceis
- Page 8 and 9: What do we need to make diagnosis o
- Page 10 and 11: Lyme diseasethe three steps of diag
- Page 13 and 14: Microbiological Epidemiology- infes
- Page 15 and 16: Lyme diseasethe three steps of diag
- Page 17 and 18: Symptoms of Lyme borreliosiskinetic
- Page 19 and 20: Early LNB• PNS manifestations.- m
- Page 21 and 22: Late neuroborreliosis• PNS manife
- Page 23 and 24: Neuroborreliosis an exemple in a re
- Page 25 and 26: Lyme diseasethe three steps of diag
- Page 27 and 28: Serology two-step approachScreening
- Page 29 and 30: Western blot• First antibodies in
- Page 31 and 32: Diagnosis criteria
- Page 33 and 34: European national neurological soci
- Page 35: Antibiotic choice for neuroborrelio
- Page 39 and 40: Treatment of nervous system Lymedis
- Page 42 and 43: Some specific situations
- Page 44 and 45: Late stage neuroborreliosis• Ther
- Page 46 and 47: Follow up• No correlation between
- Page 48 and 49: Koch’s postulate• The microorga
- Page 50 and 51: The polemic• Some patients « see
- Page 53 and 54: Aim of the study• Evaluate the po
- Page 55: Conclusion• Right diagnosis is im
Doxyxyclin and neuroborreliosis• Several studies show equivalent efficacy (200mg/day, 3 weeks) compared to ceftriaxone and highdosageintravenous penicillin• Karlsson M, et al.: Comparison <strong>of</strong> intravenous penicillin G and oral doxycycline for treatment <strong>of</strong> <strong>Lyme</strong>neuroborreliosis. Neurology 1994; 44: 1203–1207.• Dattwyler RJ, et al:Ceftriaxone compared with doxycycline for the treatment <strong>of</strong> acute disseminated <strong>Lyme</strong>borreliosis. N Engl J Med 1997; 337: 289–294.• Dotevall L, et al. Successful oral doxycycline treatment <strong>of</strong> <strong>Lyme</strong> <strong>disease</strong>-associated facial palsy and meningitis. ClinInfect Dis 1999; 28: 569–574.• In other studies, neurological complications occurredafter doxycycline treatment,– poorly diffusion into the CSF ?– When dosage increased to 400 mg/day : equivalence to ceftriaxone• Borg R, et al.: Intravenous ceftriaxone compared with oral doxycycline for the treatment <strong>of</strong><strong>Lyme</strong> neuroborreliosis. Scand J Infect Dis 2005; 37: 449–454.• Oral doxycycline as efficient as intravenousceftriaxone– inclusion criteria including patients with Bb antibodies in serum,without any other biological criteria• Ljostad Lancet Neurology, 2008 ; 7 : 6988-690.